Envoy Medical COCH Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount at other companies
Other financials
Where this comes from
Reported directly by Envoy Medical in its filing.
Tagged under the XBRL concept us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount.
The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Envoy Medical's valuation allowance, deferred tax asset, increase (decrease), amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Envoy Medical's valuation allowance, deferred tax asset, increase (decrease), amount?
- Envoy Medical (COCH) reported valuation allowance, deferred tax asset, increase (decrease), amount of -$654K in Q4 2025.
- How has Envoy Medical's valuation allowance, deferred tax asset, increase (decrease), amount changed year-over-year?
- Envoy Medical's valuation allowance, deferred tax asset, increase (decrease), amount decreased by 201.2% year-over-year, from $646.25K to -$654K.
- What is the long-term trend for Envoy Medical's valuation allowance, deferred tax asset, increase (decrease), amount?
- Over 2 years (2023 to 2025), Envoy Medical's valuation allowance, deferred tax asset, increase (decrease), amount has grown at a -32.8% compound annual growth rate (CAGR), from $5.8M to -$2.62M.
- What does valuation allowance, deferred tax asset, increase (decrease), amount mean?
- Measures the net change in the valuation allowance established against deferred tax assets, reflecting management's assessment of the likelihood that these assets will be realized. An increase in the allowance suggests reduced confidence in utilizing tax benefits in future periods.